BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2733245
Number of visits today
748
Number of downloads
2004220
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev 2021. [PMID: 34213753 DOI: 10.1007/s10741-021-10135-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Stefil M, Dixon M, Bahar J, Saied S, Mashida K, Heron O, Shantsila E, Walker L, Akpan A, Lip GY, Sankaranarayanan R. Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist. Card Fail Rev 2022. [DOI: 10.15420/cfr.2022.14] [Reference Citation Analysis]
2 Dautzenberg L, Numan L, Knol W, Gianoli M, van der Meer MG, Troost-oppelaar A, Westendorp AF, Emmelot-vonk MH, van Laake LW, Koek HL. Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation. American Heart Journal Plus: Cardiology Research and Practice 2022;24:100233. [DOI: 10.1016/j.ahjo.2022.100233] [Reference Citation Analysis]
3 Sefera B, Getachew M, Babu Y, Bekele F, Fanta K. Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study. BMC Cardiovasc Disord 2022;22:418. [PMID: 36123632 DOI: 10.1186/s12872-022-02859-4] [Reference Citation Analysis]
4 Irabor B, Mcmillan JM, Fine NM. Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.863179] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345